Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

Dreh, a long noncoding RNA repressed by metformin, regulates glucose transport in C2C12 skeletal muscle cells.

Takahashi N, Kimura AP, Otsuka K, Ohmura K, Naito S, Yoshida M, Ieko M.

Life Sci. 2019 Oct 12:116906. doi: 10.1016/j.lfs.2019.116906. [Epub ahead of print]

PMID:
31614147
2.

Characterizing long-term wear and tear of ion-selective pH sensors.

Ohmura K, Thürlimann CM, Kipf M, Carbajal JP, Villez K.

Water Sci Technol. 2019 Aug;80(3):541-550. doi: 10.2166/wst.2019.301.

PMID:
31596265
3.

Diagnosis of Bilirubin Encephalopathy in Preterm Infants with Dyskinetic Cerebral Palsy.

Kitai Y, Hirai S, Okuyama N, Hirotsune M, Mizutani S, Ogura K, Ohmura K, Okumura A, Arai H.

Neonatology. 2019 Oct 4:1-7. doi: 10.1159/000502777. [Epub ahead of print]

PMID:
31587006
4.

Nakajo-Nishimura syndrome and related proteasome-associated autoinflammatory syndromes.

Ohmura K.

J Inflamm Res. 2019 Sep 17;12:259-265. doi: 10.2147/JIR.S194098. eCollection 2019.

5.

A Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy with High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.

Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, Hirata S, Nojima T, Sugiyama E, Hatta K, Taguchi Y, Katayama M, Tanizawa K, Handa T, Uozumi R, Akizuki S, Murakami K, Hashimoto M, Tanaka M, Ohmura K, Mimori T.

Arthritis Rheumatol. 2019 Sep 16. doi: 10.1002/art.41105. [Epub ahead of print]

PMID:
31524333
6.

Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor.

Ishikawa Y, Ikari K, Hashimoto M, Ohmura K, Tanaka M, Ito H, Taniguchi A, Yamanaka H, Mimori T, Terao C.

Ann Rheum Dis. 2019 Nov;78(11):1480-1487. doi: 10.1136/annrheumdis-2019-215463. Epub 2019 Aug 19.

PMID:
31427439
7.

Persistent anemia and hypoalbuminemia in rheumatoid arthritis patients with low serum triiodothyronine level.

Tsuji H, Hashimoto M, Harada T, Tanaka M, Ito H, Murakami K, Ohmura K, Fujii T, Mimori T.

Mod Rheumatol. 2019 Aug 8:1-8. doi: 10.1080/14397595.2019.1649109. [Epub ahead of print]

PMID:
31393192
8.

Lupus anticoagulant-hypoprothrombinemia syndrome and similar diseases: experiences at a single center in Japan.

Ieko M, Yoshida M, Naito S, Ohmura K, Takahashi N.

Int J Hematol. 2019 Aug;110(2):197-204. doi: 10.1007/s12185-019-02674-2. Epub 2019 Jun 4.

PMID:
31165409
9.

Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis.

Ishigooka N, Fujii T, Abe H, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Ito H, Ohmura K, Morita S, Mimori T.

Mod Rheumatol. 2019 Jun 13:1-8. doi: 10.1080/14397595.2019.1621439. [Epub ahead of print]

PMID:
31116051
10.

Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39.

Spiliopoulou A, Colombo M, Plant D, Nair N, Cui J, Coenen MJ, Ikari K, Yamanaka H, Saevarsdottir S, Padyukov L, Bridges SL Jr, Kimberly RP, Okada Y, van Riel PLC, Wolbink G, van der Horst-Bruinsma IE, de Vries N, Tak PP, Ohmura K, Canhão H, Guchelaar HJ, Huizinga TW, Criswell LA, Raychaudhuri S, Weinblatt ME, Wilson AG, Mariette X, Isaacs JD, Morgan AW, Pitzalis C, Barton A, McKeigue P.

Ann Rheum Dis. 2019 Aug;78(8):1055-1061. doi: 10.1136/annrheumdis-2018-214877. Epub 2019 Apr 29.

11.

Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation.

Matsuo T, Hashimoto M, Sakaguchi S, Sakaguchi N, Ito Y, Hikida M, Tsuruyama T, Sakai K, Yokoi H, Shirakashi M, Tanaka M, Ito H, Yoshifuji H, Ohmura K, Fujii T, Mimori T.

J Immunol. 2019 Jun 1;202(11):3161-3172. doi: 10.4049/jimmunol.1801159. Epub 2019 Apr 24.

PMID:
31019063
12.

Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss.

Ohmura K, Oku K, Kitaori T, Amengual O, Hisada R, Kanda M, Shimizu Y, Fujieda Y, Kato M, Bohgaki T, Horita T, Yasuda S, Sugiura-Ogasawara M, Atsumi T.

Clin Immunol. 2019 Jun;203:37-44. doi: 10.1016/j.clim.2019.04.005. Epub 2019 Apr 8.

PMID:
30974291
13.

Bioactive TiNbSn alloy prepared by anodization in sulfuric acid electrolytes.

Masahashi N, Mori Y, Tanaka H, Kogure A, Inoue H, Ohmura K, Kodama Y, Nishijima M, Itoi E, Hanada S.

Mater Sci Eng C Mater Biol Appl. 2019 May;98:753-763. doi: 10.1016/j.msec.2019.01.033. Epub 2019 Jan 10.

PMID:
30813081
14.

Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis.

Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T.

Mod Rheumatol. 2019 Feb 21:1-5. doi: 10.1080/14397595.2019.1583819. [Epub ahead of print]

PMID:
30789095
15.

Utility of osteopontin in cerebrospinal fluid as a diagnostic marker for neuropsychiatric systemic lupus erythematosus.

Kitagori K, Yoshifuji H, Oku T, Ayaki T, Kuzuya A, Nakajima T, Akizuki S, Nakashima R, Murakami K, Ohmura K, Hirayama Y, Takahashi R, Mimori T.

Lupus. 2019 Mar;28(3):414-422. doi: 10.1177/0961203319828818. Epub 2019 Feb 11.

PMID:
30744522
16.

PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune phenotypes.

Akizuki S, Ishigaki K, Kochi Y, Law SM, Matsuo K, Ohmura K, Suzuki A, Nakayama M, Iizuka Y, Koseki H, Ohara O, Hirata J, Kamatani Y, Matsuda F, Sumida T, Yamamoto K, Okada Y, Mimori T, Terao C.

Ann Rheum Dis. 2019 Apr;78(4):509-518. doi: 10.1136/annrheumdis-2018-214116. Epub 2019 Jan 24.

PMID:
30679154
17.

Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.

Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13045-13050. doi: 10.1073/pnas.1808850115. Epub 2018 Nov 29.

18.

Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis.

Nishioka A, Tsunoda S, Abe T, Yoshikawa T, Takata M, Kitano M, Matsui K, Nakashima R, Hosono Y, Ohmura K, Mimori T, Sano H.

Mod Rheumatol. 2019 Sep;29(5):814-820. doi: 10.1080/14397595.2018.1548918. Epub 2019 Feb 7.

PMID:
30449228
19.

Biallelic COLGALT1 variants are associated with cerebral small vessel disease.

Miyatake S, Schneeberger S, Koyama N, Yokochi K, Ohmura K, Shiina M, Mori H, Koshimizu E, Imagawa E, Uchiyama Y, Mitsuhashi S, Frith MC, Fujita A, Satoh M, Taguri M, Tomono Y, Takahashi K, Doi H, Takeuchi H, Nakashima M, Mizuguchi T, Takata A, Miyake N, Saitsu H, Tanaka F, Ogata K, Hennet T, Matsumoto N.

Ann Neurol. 2018 Dec;84(6):843-853. doi: 10.1002/ana.25367. Epub 2018 Nov 30.

PMID:
30412317
20.

Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity.

Sakaue S, Hirata J, Maeda Y, Kawakami E, Nii T, Kishikawa T, Ishigaki K, Terao C, Suzuki K, Akiyama M, Suita N, Masuda T, Ogawa K, Yamamoto K, Saeki Y, Matsushita M, Yoshimura M, Matsuoka H, Ikari K, Taniguchi A, Yamanaka H, Kawaji H, Lassmann T, Itoh M, Yoshitomi H, Ito H, Ohmura K, R Forrest AR, Hayashizaki Y, Carninci P, Kumanogoh A, Kamatani Y, de Hoon M, Yamamoto K, Okada Y.

Nucleic Acids Res. 2018 Dec 14;46(22):11898-11909. doi: 10.1093/nar/gky1066.

21.

Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study.

Matsuo T, Hashimoto M, Ito I, Kubo T, Uozumi R, Furu M, Ito H, Fujii T, Tanaka M, Terao C, Kono H, Mori M, Hamaguchi M, Yamamoto W, Ohmura K, Morita S, Mimori T.

Scand J Rheumatol. 2019 Mar;48(2):87-94. doi: 10.1080/03009742.2018.1477989. Epub 2018 Sep 30.

PMID:
30269670
22.

Significant joint-destructive association of HLA-DRB1*04:05 independent of DAS28 in rheumatoid arthritis.

Tsuji H, Ikari K, Ohmura K, Yano K, Furu M, Hashimoto M, Ito H, Fujii T, Yamamoto W, Taniguchi A, Yamanaka H, Mimori T, Terao C.

Ann Rheum Dis. 2019 Feb;78(2):284-286. doi: 10.1136/annrheumdis-2018-214022. Epub 2018 Sep 19. No abstract available.

PMID:
30232193
23.

Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.

Hashimoto M, Furu M, Yamamoto W, Fujimura T, Hara R, Katayama M, Ohnishi A, Akashi K, Yoshida S, Nagai K, Son Y, Amuro H, Hirano T, Ebina K, Uozumi R, Ito H, Tanaka M, Ohmura K, Fujii T, Mimori T.

Arthritis Res Ther. 2018 Aug 3;20(1):165. doi: 10.1186/s13075-018-1673-1.

24.

Anti-EJ, anti-MDA5 double-positive chronic clinically amyopathic dermatomyositis: a case report.

Takeuchi Y, Hashimoto M, Nakashima R, Tanaka M, Kuramoto N, Murakami K, Yoshifuji H, Ohmura K, Mimori T.

Rheumatol Adv Pract. 2018 Jun 23;2(2):rky022. doi: 10.1093/rap/rky022. eCollection 2018. No abstract available.

25.

Predictive factors for structural remission using abatacept: Results from the ABROAD study.

Murakami K, Sekiguchi M, Hirata S, Fujii T, Matsui K, Morita S, Ohmura K, Kawahito Y, Nishimoto N, Mimori T, Sano H; ABROAD study investigators.

Mod Rheumatol. 2019 May;29(3):406-412. doi: 10.1080/14397595.2018.1482609. Epub 2018 Jun 27.

PMID:
29807445
26.

Basic Evaluation of the Newly Developed "Lias Auto P-FDP" Assay and the Influence of Plasmin-α2 Plasmin Inhibitor Complex Values on Discrepancy in the Comparison with "Lias Auto D-Dimer Neo" Assay.

Kumano O, Ieko M, Komiyama Y, Naito S, Yoshida M, Takahashi N, Ohmura K, Hayasaki J, Hayakawa M.

Clin Lab. 2018 Apr 1;64(4):433-442. doi: 10.7754/Clin.Lab.2017.170902.

PMID:
29739066
27.

Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis.

Ohmura K, Kato M, Watanabe T, Oku K, Bohgaki T, Horita T, Yasuda S, Ito YM, Sato N, Atsumi T.

Arthritis Res Ther. 2018 Apr 17;20(1):72. doi: 10.1186/s13075-018-1589-9.

28.

Infantile spasms related to a 5q31.2-q31.3 microdeletion including PURA.

Shimojima K, Okamoto N, Ohmura K, Nagase H, Yamamoto T.

Hum Genome Var. 2018 Mar 29;5:18007. doi: 10.1038/hgv.2018.7. eCollection 2018.

29.

Drs. Nakabo and Ohmura reply.

Nakabo S, Ohmura K.

J Rheumatol. 2018 Mar;45(3):439-440. doi: 10.3899/jrheum.171415. No abstract available.

PMID:
29496918
30.

Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome.

Nakamura H, Oku K, Ogata Y, Ohmura K, Yoshida Y, Kitano E, Fujieda Y, Kato M, Bohgaki T, Amengual O, Yasuda S, Fujimura Y, Seya T, Atsumi T.

Thromb Res. 2018 Apr;164:63-68. doi: 10.1016/j.thromres.2018.02.142. Epub 2018 Feb 21.

PMID:
29494857
31.

HLA-DRB1 Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide Antibodies.

Hiwa R, Ikari K, Ohmura K, Nakabo S, Matsuo K, Saji H, Yurugi K, Miura Y, Maekawa T, Taniguchi A, Yamanaka H, Matsuda F, Mimori T, Terao C.

J Rheumatol. 2018 Apr;45(4):470-480. doi: 10.3899/jrheum.170363. Epub 2018 Feb 1.

PMID:
29419463
32.

[A case of anti-PL-7 antibody positive polymyositis with thrombotic microangiopathy].

Tamura M, Kitano M, Azuma K, Tsuboi K, Abe T, Ogita C, Yokoyama Y, Furukawa T, Yoshikawa T, Saito A, Nishioka A, Sekiguchi M, Azuma N, Tsunoda S, Hosono Y, Nakashima R, Ohmura K, Matsui K, Mimori T, Sano H.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):450-455. doi: 10.2177/jsci.40.450. Japanese.

33.

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.

Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.

Ann Rheum Dis. 2018 Apr;77(4):602-611. doi: 10.1136/annrheumdis-2017-212149. Epub 2018 Jan 13.

PMID:
29331962
34.

Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosus.

Tanimura S, Fujieda Y, Kono M, Shibata Y, Hisada R, Sugawara E, Nakamura H, Ohmura K, Shimamura S, Mitani A, Shida H, Watanabe T, Kato M, Oku K, Bohgaki T, Amengual O, Yasuda S, Shimizu C, Atsumi T.

Mod Rheumatol. 2018 Sep;28(5):865-871. doi: 10.1080/14397595.2017.1408755. Epub 2017 Dec 14.

PMID:
29239264
35.

Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-naïve lupus nephritis, but not in those under immunosuppressive treatment.

Shimizu Y, Yasuda S, Kimura T, Nishio S, Kono M, Ohmura K, Shimamura S, Kono M, Fujieda Y, Kato M, Oku K, Bohgaki T, Fukasawa Y, Tanaka S, Atsumi T.

Mod Rheumatol. 2018 Jul;28(4):661-669. doi: 10.1080/14397595.2017.1404711. Epub 2017 Nov 30.

PMID:
29189089
36.

Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).

Oku K, Atsumi T, Akiyama Y, Amano H, Azuma N, Bohgaki T, Asanuma YF, Horita T, Hosoya T, Ichinose K, Kato M, Katsumata Y, Kawaguchi Y, Kawakami A, Koga T, Kohsaka H, Kondo Y, Kubo K, Kuwana M, Mimori A, Mimori T, Mimura T, Murakami K, Nakano K, Nakayamada S, Ogishima H, Ohmura K, Saito K, Sano H, Shibuya M, Takahashi Y, Takasaki Y, Takeuchi T, Tamura N, Tanaka Y, Tsuboi H, Tsunoda S, Yukawa N, Yamakawa N, Yamamoto K, Sumida T.

Mod Rheumatol. 2018 Jul;28(4):642-648. doi: 10.1080/14397595.2017.1385154. Epub 2017 Nov 9.

PMID:
29120258
37.

Genetic landscape of interactive effects of HLA-DRB1 alleles on susceptibility to ACPA(+) rheumatoid arthritis and ACPA levels in Japanese population.

Terao C, Okada Y, Ikari K, Kochi Y, Suzuki A, Ohmura K, Matsuo K, Taniguchi A, Kubo M, Raychaudhuri S, Yamamoto K, Yamanaka H, Kamatani Y, Mimori T, Matsuda F.

J Med Genet. 2017 Dec;54(12):853-858. doi: 10.1136/jmedgenet-2017-104779. Epub 2017 Oct 12.

38.

Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice.

Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T.

Mod Rheumatol. 2018 Jul;28(4):626-636. doi: 10.1080/14397595.2017.1380249. Epub 2017 Oct 3.

PMID:
28972439
39.

A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production.

Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T.

Arthritis Res Ther. 2017 Sep 6;19(1):197. doi: 10.1186/s13075-017-1408-8.

40.

Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis.

Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C.

Sci Rep. 2017 Jul 31;7(1):6911. doi: 10.1038/s41598-017-07137-4.

41.

Time-averaged disease activity fits better joint destruction in rheumatoid arthritis.

Tsuji H, Yano K, Furu M, Yamakawa N, Ikari K, Hashimoto M, Ito H, Fujii T, Yamamoto W, Ohmura K, Taniguchi A, Momohara S, Matsuda F, Allaart CF, Yamanaka H, Mimori T, Terao C.

Sci Rep. 2017 Jul 19;7(1):5856. doi: 10.1038/s41598-017-05581-w.

42.

Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis.

Murata K, Fang C, Terao C, Giannopoulou EG, Lee YJ, Lee MJ, Mun SH, Bae S, Qiao Y, Yuan R, Furu M, Ito H, Ohmura K, Matsuda S, Mimori T, Matsuda F, Park-Min KH, Ivashkiv LB.

Immunity. 2017 Jul 18;47(1):66-79.e5. doi: 10.1016/j.immuni.2017.06.018.

43.

First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β2 -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies Tests.

Nakamura H, Oku K, Amengual O, Ohmura K, Fujieda Y, Kato M, Bohgaki T, Yasuda S, Atsumi T.

Arthritis Care Res (Hoboken). 2018 Apr;70(4):627-634. doi: 10.1002/acr.23310.

44.

Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies.

Watanabe T, Oku K, Amengual O, Hisada R, Ohmura K, Nakagawa I, Shida H, Bohgaki T, Horita T, Yasuda S, Atsumi T.

Lupus. 2018 Feb;27(2):225-234. doi: 10.1177/0961203317716787. Epub 2017 Jun 28.

45.

Myeloperoxidase/HLA Class II Complexes Recognized by Autoantibodies in Microscopic Polyangiitis.

Hiwa R, Ohmura K, Arase N, Jin H, Hirayasu K, Kohyama M, Suenaga T, Saito F, Terao C, Atsumi T, Iwatani H, Mimori T, Arase H.

Arthritis Rheumatol. 2017 Oct;69(10):2069-2080. doi: 10.1002/art.40170. Epub 2017 Aug 25.

46.

Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.

Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K.

J Rheumatol. 2017 Sep;44(9):1384-1388. doi: 10.3899/jrheum.161432. Epub 2017 May 15.

PMID:
28507178
47.

Novel autoantibody against the β2-glycoprotein I/human leucocyte antigen-DR complex in patients with refractory cutaneous ulcers.

Arase N, Tanimura K, Jin H, Yamaoka T, Kishibe M, Nishioka M, Kiyohara E, Tani M, Matsuoka S, Ohmura K, Takasugi K, Yamamoto T, Murota H, Arase H, Katayama I.

Br J Dermatol. 2018 Jan;178(1):272-275. doi: 10.1111/bjd.15571. Epub 2017 Oct 6. No abstract available.

PMID:
28403571
48.

Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies.

Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K.

Rheumatology (Oxford). 2017 Jul 1;56(7):1217-1226. doi: 10.1093/rheumatology/kex088.

49.

Clinical Images: Chronic Nonbacterial Osteomyelitis.

Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T.

Arthritis Rheumatol. 2017 Aug;69(8):1660. doi: 10.1002/art.40108. Epub 2017 Jul 5. No abstract available.

50.

Two-dimensional growth of crystalline nanofiber fabricated from Gemini-type amphiphilic diamide derivative inducing the thixotropic property.

Iizuka M, Nakagawa Y, Ohmura K, Satou E, Fujimori A.

J Colloid Interface Sci. 2017 Jul 15;498:64-75. doi: 10.1016/j.jcis.2017.03.016. Epub 2017 Mar 4.

PMID:
28319842

Supplemental Content

Loading ...
Support Center